Search results: Sage Journals

Restricted accessResearch articleFirst published March, 2026

The dual barriers to biosimilar competition: A comparative analysis of US patent thickets and EU supplementary protection certificates

Raviraj Kadam

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessResearch articleFirst published June, 2003

THe Latest Thinking on Best Strategies for Use of Supplementary Certificates

Julian Hitchcock, Bülent Tugal

Journal of Medical Marketing: Device,Diagnostic and Pharmaceutical Marketing

Restricted accessCase reportFirst published December, 2017

Sandoz & Hexal v Searle & Janssen Sciences Ireland : What is the formula for patent term extensions?

Chris Hayes

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessResearch articleFirst published February, 2011

The extension of the exclusive right to pharmaceuticals under the European law: The Supplementary Protection Certificate

Fidel Porcuna de la Rosa

Pharmaceuticals Policy and Law

Restricted accessNewsFirst published July, 1986

{BLR 543}Text: Reexamination Certificate U.S. Patent 4,358,535 Falkow Et Al

Biotechnology Law Report

Restricted accessOtherFirst published May, 1982

Bill In Congress Would Give Capital Gains Treatment To Plant Variety Certificates And Patents Bought From Universities

Biotechnology Law Report

Restricted accessResearch articleFirst published November, 2008

House of Lords Provides Guidance on the Law of Obviousness in Patent Actions;Increased Opportunities to Obtain Supplementary Protection Certificates for Combinations of Active Ingredients;Patent for DNA and Protein Sequence Invalid Due to Lack of Industrial Application

Michael Burdon, James Armstrong, Catherine Katzka [...]

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessResearch articleFirst published August, 2013

Preliminary Ruling of the Court of Justice of the European Union in Neurim Pharmaceuticals (1991) Ltd. v. Comptroller-General of Patents on Supplementary Protection Certificates in Europe

By Li Westerlund

Biotechnology Law Report

Restricted accessResearch articleFirst published December, 2012

Preliminary Ruling of the Court of Justice of the European Union in Neurim Pharmaceuticals (1991) Ltd. v. Comptroller–General of Patents on Supplementary Protection Certificates in Europe

By Li Westerlund

Biotechnology Law Report

Restricted accessResearch articleFirst published February, 2014

Recent developments in the area of supplementary protection certificates

Ulrich M. Gassner

Pharmaceuticals Policy and Law

Restricted accessResearch articleFirst published March, 2026

The dual barriers to biosimilar competition: A comparative analysis of US patent thickets and EU supplementary protection certificates

Raviraj Kadam

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessResearch articleFirst published June, 2003

THe Latest Thinking on Best Strategies for Use of Supplementary Certificates

Julian Hitchcock, Bülent Tugal

Journal of Medical Marketing: Device,Diagnostic and Pharmaceutical Marketing

Restricted accessCase reportFirst published December, 2017

Sandoz & Hexal v Searle & Janssen Sciences Ireland : What is the formula for patent term extensions?

Chris Hayes

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessResearch articleFirst published February, 2011

The extension of the exclusive right to pharmaceuticals under the European law: The Supplementary Protection Certificate

Fidel Porcuna de la Rosa

Pharmaceuticals Policy and Law

Restricted accessNewsFirst published July, 1986

{BLR 543}Text: Reexamination Certificate U.S. Patent 4,358,535 Falkow Et Al

Biotechnology Law Report

Restricted accessOtherFirst published May, 1982

Bill In Congress Would Give Capital Gains Treatment To Plant Variety Certificates And Patents Bought From Universities

Biotechnology Law Report

Restricted accessResearch articleFirst published November, 2008

House of Lords Provides Guidance on the Law of Obviousness in Patent Actions;Increased Opportunities to Obtain Supplementary Protection Certificates for Combinations of Active Ingredients;Patent for DNA and Protein Sequence Invalid Due to Lack of Industrial Application

Michael Burdon, James Armstrong, Catherine Katzka [...]

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessResearch articleFirst published August, 2013

Preliminary Ruling of the Court of Justice of the European Union in Neurim Pharmaceuticals (1991) Ltd. v. Comptroller-General of Patents on Supplementary Protection Certificates in Europe

By Li Westerlund

Biotechnology Law Report

Restricted accessResearch articleFirst published December, 2012

Preliminary Ruling of the Court of Justice of the European Union in Neurim Pharmaceuticals (1991) Ltd. v. Comptroller–General of Patents on Supplementary Protection Certificates in Europe

By Li Westerlund

Biotechnology Law Report

Restricted accessResearch articleFirst published February, 2014

Recent developments in the area of supplementary protection certificates

Ulrich M. Gassner

Pharmaceuticals Policy and Law